Sushanta Halder

Also affiliated with University of Nebraska Medical Center

MedicineChemistryEnvironmental Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Sildenafil Potentiates the Therapeutic Efficacy of Docetaxel in Advanced Prostate Cancer by Stimulating NO-cGMP Signaling”.

Sildenafil Potentiates the Therapeutic Efficacy of Docetaxel in Advanced Prostate Cancer by Stimulating NO-cGMP Signaling

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-1569

N/A

0.564DataRank · unranked

42 citations

Satyanarayana Rachagani, Seema Parte, Sushanta Halder, Parthasarathy Seshacharyulu, Prakash Kshirsagar +12 more

Disruption of FDPS/Rac1 axis radiosensitizes pancreatic ductal adenocarcinoma by attenuating DNA damage response and immunosuppressive signalling

EBioMedicine(2021)10.1016/j.ebiom.2021.103772

N/A

0DataRank · unranked

29 citations

Sushanta Halder, Rama Krishna Nimmakayala, Satyanarayana Rachagani, Sanjib Chaudhary, Pranita Atri +22 more

The Pleiotropic role, functions and targeted therapies of LIF/LIFR axis in cancer: Old spectacles with new insights

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer(2022)10.1016/j.bbcan.2022.188737

N/A

0DataRank · unranked

33 citations

Seema Parte, Prakash Kshirsagar, Sakthivel Muniyan, Hareesh B. Nair, Surinder K. Batra +2 more

Small molecule inhibitor against onco-mucins disrupts Src/FosL1 axis to enhance gemcitabine efficacy in pancreatic ductal adenocarcinoma

Cancer Letters(2022)10.1016/j.canlet.2022.215922

N/A

0DataRank · unranked

17 citations

Pranita Atri, Palanisamy Nallasamy, Seema Parte, Sanchita Rauth, Rama Krishna Nimmakayala +14 more

Targeting the EGFR signaling pathway in cancer therapy: What’s new in 2023?

Expert Opinion on Therapeutic Targets(2023)10.1080/14728222.2023.2218613

N/A

0DataRank · unranked

89 citations

Soumi Basu, Shobhit P. Lall, Apar Kishor Ganti, Surinder K. Batra, Parthasarathy Seshacharyulu +1 more